4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-061843
Chief Medical Officer sold 6,890 shares at an average $20.01 ($137,835)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-12-19 | Sale | −2,566 | $20.00 | $51,320 | 4,324 | D |
| Ho Carole Chief Medical Officer | 2019-12-20 | Sale | −860 | $20.00 | $17,200 | 3,464 | D |
| Ho Carole Chief Medical Officer | 2019-12-23 | Sale | −3,464 | $20.01 | $69,315 | 0 | D |
| Open-market sales · 6,890 sh · avg $20.01 · $137,835 | |||||||
Loading xslF345X03/doc4.xml…